Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.44
-4 %
$ 156 M
Market Cap
-0.8
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
25.68%
EBIT
Estimate
--39.60%
Net Income
Estimate
20.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
OrganiGram Holdings Inc.
OGI has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart OGI
EBIT FORECAST
EBIT Forecast Chart OGI
NET INCOME FORECAST
Net Income Chart OGI